EIGA Document 203/16 – Typical Post-Marketing Pharmacovigilance Cases in the Medical Gases Industry

The administration of medicinal gases requires the use of medical devices, and it is sometimes difficult to define incidents and differentiate between materiovigilance and pharmacovigilance. This publication also gives guidance for these typical cases, if they shall be classified as materiovigilance and/or pharmacovigilance cases.


By having harmonized practices and a consistent approach throughout industry regarding the classification and reporting of typical post-marketing cases, this will help facilitate product safety profile follow up or updates for the benefit of patients.  This publication is intended for any personnel involved in pharmacovigilance activities within EIGA member companies.


This publication can be viewed or downloaded on the EIGA Website by clicking here.  You can view or download many other EIGA publications at the following address: www.eiga.eu.

12 September 2016

Back to news page